Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Current Deferred Tax Assets (2019 - 2021)

Opus Genetics has reported Current Deferred Tax Assets over the past 2 years, most recently at $88000.0 for Q1 2021.

  • Quarterly Current Deferred Tax Assets changed N/A to $88000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $88000.0 through Mar 2021, changed N/A year-over-year, with the annual reading at $76000.0 for FY2019, N/A changed from the prior year.
  • Current Deferred Tax Assets was $88000.0 for Q1 2021 at Opus Genetics, up from $76000.0 in the prior quarter.
  • Over five years, Current Deferred Tax Assets peaked at $88000.0 in Q1 2021 and troughed at $76000.0 in Q4 2019.